Early-Stop trial tests new drug combo for tough pancreatic cancer
Disease control
Terminated
This study tested whether adding an experimental drug called NIS793 to a standard chemotherapy combination (FOLFIRINOX) could help people with metastatic pancreatic cancer. The goal was to see if the new combination was safe and could help shrink tumors enough for surgery. The tr…
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated Apr 02, 2026 00:56 UTC